Lipella Pharmaceuticals Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Kaufman Jonathan H, was filed 15 May 2024.
Lipella Pharmaceuticals Inc.: what insiders have been doing
Lipella Pharmaceuticals Inc. belongs to the Health Care sector. Filings by its managers are published through SEC (Form 4). Lipella Pharmaceuticals Inc. has had no insider filing for more than a year; the last one goes back to 15 May 2024.
The full history, which starts in 2022, counts 3 purchases against no sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Since the insiders bought
- -64.3%Entry US$6.10 · Close at T+365 US$2.18
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2024FY ended December 2024 · cache
- 10,000 shares@ US$0.7595.8% of flowCommon StockSEC:0001753926-24-000984:0Canonical exit: 12 Aug 2024 (T+90)
- 25,000 shares@ US$0.8721Common StockSEC:0001753926-24-000573:1Canonical exit: 17 Jun 2024 (T+90)
- 30,000 shares@ US$0.788318.1% of flowCommon StockSEC:0001753926-24-000573:0Canonical exit: 16 Jun 2024 (T+90)
- 144,906 shares@ US$0.6901100.0% of flowCommon StockSEC:0001753926-24-000539:0
- 144,906 shares@ US$0.690176.1% of flowCommon StockSEC:0001753926-24-000541:0
- 22,950 shares@ US$5.75100.0% of flowCommon StockSEC:0001753926-22-001648:0
6 of 6 declarations
About Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc. is a company focused on developing innovative pharmaceutical treatments. It is listed on the NASDAQ.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
